Topic Contents
Calcium
Uses
Related Topics
Calcium is the most abundant, essential mineral in the human body. Of the two to three pounds of calcium contained in the average body, 99% is located in the bones and teeth. Calcium is needed to form bones and teeth and is also required for blood clotting, transmission of signals in nerve cells, and muscle contraction. The importance of calcium for preventing osteoporosis is probably its most well-known role.
What Are "Star" Ratings?
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.
Our proprietary “Star-Rating” system was developed to help you easily understand the amount of scientific support behind each supplement in relation to a specific health condition. While there is no way to predict whether a vitamin, mineral, or herb will successfully treat or prevent associated health conditions, our unique ratings tell you how well these supplements are understood by the medical community, and whether studies have found them to be effective for other people.
For over a decade, our team has combed through thousands of research articles published in reputable journals. To help you make educated decisions, and to better understand controversial or confusing supplements, our medical experts have digested the science into these three easy-to-follow ratings. We hope this provides you with a helpful resource to make informed decisions towards your health and well-being.
This supplement has been used in connection with the following health conditions:
| Used for | Amount | Why |
|---|---|---|
|
Gestational Hypertension
|
1,200 to 1,500 mg daily |
Supplementing with calcium may reduce the risk of gestational hypertension. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Lactose Intolerance and Calcium Deficiency
|
500 to 1,200 mg daily depending on age and other calcium sources |
As lactose-containing foods are among the best dietary sources of calcium, lactose-intolerant people may want to use calcium supplements as an alternative source. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Osteoporosis
|
800 to 1,500 mg daily depending on age and dietary calcium intake |
Calcium supplements help prevent osteoporosis, especially for girls and premenopausal women. It is often recommended to help people already diagnosed with osteoporosis. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Preeclampsia and High-Risk Women
|
1,200 to 1,500 mg daily |
An analysis of double-blind trials found calcium supplementation to be highly effective in preventing preeclampsia. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Premenstrual Syndrome
|
1,000 to 1,200 mg daily |
Calcium appears to reduce the risk of mood swings, bloating, headaches, and other PMS symptoms. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Rickets
|
Consult a qualified healthcare practitioner |
Calcium supplements may be helpful in preventing and treating rickets. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Breast-Feeding Support
|
1,000 mg daily |
Continuing to take prenatal vitamins will help ensure your body gets the nutrients it needs for breast-feeding. Especially important is continued calcium intake. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Celiac Disease and Calcium Deficiency
|
Consult a qualified healthcare practitioner |
The malabsorption that occurs in celiac disease can lead to multiple nutritional deficiencies. Supplementing with calcium may correct a deficiency. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
High Cholesterol
|
800 to 1,000 mg daily |
Some trials have shown that supplementing with calcium reduces cholesterol levels. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
High Triglycerides
|
800 mg daily |
Calcium supplementation has been shown to reduce triglyceride levels. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Hypertension
|
800 to 1,500 mg daily |
Calcium supplementation has been shown to lower blood pressure in people with hypertension. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Obesity
|
800 mg daily |
In a study of obese people following a low-calorie diet, those receiving a calcium supplement lost significantly more weight than those given a placebo. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Pregnancy and Postpartum Support
|
Obtain a total of 1,500 to 2,000 mg daily, including both supplement and food sources |
Calcium needs double during pregnancy. Supplementing with calcium may reduce the risk of preeclampsia and pre-term delivery and improve the bone strength of the fetuses. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Amenorrhea and Osteoporosis
(Vitamin D) |
Refer to label instructions |
Despite the lack of evidence that calcium and vitamin D supplements alone are helpful to amenorrheic women, they are still generally recommended to prevent the added burden of calcium and vitamin D deficiency from further contributing to bone loss. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Colon Cancer
|
Refer to label instructions |
Through a variety of mechanisms, calcium appears to reduce precancerous conditions in the colon and the risk of colon cancer. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Depression
|
Refer to label instructions |
Taken with vitamin D, calcium significantly improved mood in people without depression in one study. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Dysmenorrhea
|
Refer to label instructions |
Muscles that are calcium-deficient tend to be hyperactive and therefore might be more likely to cramp. Calcium may help prevent menstrual cramps by maintaining normal muscle tone. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Gingivitis
|
Refer to label instructions |
Some doctors recommend calcium to people with gum diseases. Calcium given to people with periodontal disease has been shown to reduce bleeding of the gums and loose teeth. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Insulin Resistance Syndrome
|
Refer to label instructions |
One study found that supplementing with calcium improved insulin sensitivity in people with hypertension. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Kidney Stones in People Who Are Not Hyperabsorbers of Calcium
|
Refer to label instructions |
Calcium appears to interfere with the absorption of oxalate, which reduces the risk of stone formation. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Migraine Headache
|
Refer to label instructions |
Taking large amounts of the combination of calcium and vitamin D has been reported to produce a marked reduction in the incidence of migraines in several women. |
|
||
| Used for | Amount | Why |
|---|---|---|
|
Multiple Sclerosis
|
Refer to label instructions |
Calcium levels have been reported to be low in people with MS. In one study, people given a combination of cod liver oil, magnesium, and calcium had a significantly reduced number of MS attacks. |
|
||
How It Works
How to Use It
The National Academy of Sciences has established guidelines for calcium that are 25–50% higher than previous recommendations. For ages 19 to 50, calcium intake is recommended to be 1,000 mg daily; for adults over age 51, the recommendation is 1,200 mg daily.118 The most common supplemental amount for adults is 800–1,000 mg per day.119 General recommendations for higher daily intakes (1,200–1,500 mg) usually include the calcium most people consume from their diets. Studies indicate the average daily amount of calcium consumed by Americans is about 500–1,000 mg.
Where to Find It
Most dietary calcium comes from dairy products. The myth that calcium from dairy products is not absorbed is not supported by scientific research.120 , 121 Other good sources include sardines, canned salmon, green leafy vegetables, and tofu.
Possible Deficiencies
Severe deficiency of either calcium or vitamin D leads to a condition called rickets in children and osteomalacia in adults. Since vitamin D is required for calcium absorption, people with conditions causing vitamin D deficiency (e.g., pancreatic insufficiency) may develop a deficiency of calcium as well. Vegans (pure vegetarians), people with dark skin, those who live in northern latitudes, and people who stay indoors almost all the time are more likely to be vitamin D deficient than are other people. Vegans often eat less calcium and vitamin D than do other people. Most people eat well below the recommended amount of calcium. This lack of dietary calcium is thought to contribute to the risk of osteoporosis, particularly in white and Asian women.
Interactions
Interactions with Supplements, Foods, & Other Compounds
Some studies have shown that calcium competes for absorption with a number of other minerals, while other studies have found no such competition. To be on the safe side, some doctors recommend that people taking calcium for long periods of time should also take a multimineral supplement.
One study has shown that taking calcium can interfere with the absorption of phosphorus, which, like calcium, is important for bone health.122. Although most western diets contain ample or even excessive amounts of phosphorus, older people who supplement with large amounts of calcium may be at risk of developing phosphorus deficiency. For this reason, the authors of this study recommend that, for elderly people, at least some of the supplemental calcium be taken in the form of tricalcium phosphate or some other phosphorus-containing preparation.
Vitamin D ’s most important role is maintaining blood levels of calcium. Therefore, many doctors recommend that those supplementing with calcium also supplement with 400 IU of vitamin D per day.
Animal studies have shown that essential fatty acids (EFAs) increase calcium absorption from the gut, in part by enhancing the effects of vitamin D and reducing loss of calcium in the urine.123
Lysine supplementation increases the absorption of calcium and may reduce its excretion.124 As a result, some researchers believe that lysine may eventually be shown to have a role in the prevention and treatment of osteoporosis.125
Interactions with Medicines
Certain medicines interact with this supplement.
|
|
Some medicines may increase the need for this supplement. |
|---|---|
|
|
Some medicines interact with this supplement, so they should not be taken together. |
|
|
Some interactions between this supplement and certain medicines require more explanation. Click the link to see details. |
Note: The following list only includes the generic or class name of a medicine. To find a specific brand name, use the Medicines Index.
Side Effects
Side Effects
Constipation , bloating, and gas are sometimes reported with the use of calcium supplements.126 A very high intake of calcium from dairy products combined with large amounts of supplemental calcium carbonate (used as an antacid) was reported in the past to cause a condition called “milk alkali syndrome.” This toxicity is rarely reported today because most medical doctors no longer tell people with ulcers to use this approach as treatment for their condition.
People with hyperparathyroidism, chronic kidney disease, or kidney stones should not supplement with calcium without consulting a physician. For other adults, the highest amount typically suggested by doctors (1,200 mg per day) typically does not cause side effects. People with prostate cancer should avoid supplementing with calcium without medical supervision.
A combined analysis of 15 controlled trials found that long-term calcium supplementation was associated with a significant increase of approximately 30% in the incidence of myocardial infarctions (heart attacks).127 Since these studies were not designed to examine the effect of calcium on heart attack risk, it is possible that the findings in this post hoc (after the fact) analysis were due to chance. A more recent study found that long-term calcium supplementation did not result in an increased incidence of cardiovascular disease-related death or hospitalization.128
In the past, calcium supplements in the forms of bone meal (including microcrystalline hydroxyapatite [MCHC]), dolomite, and oyster shell have sometimes had higher lead levels than permitted by stringent California regulations, though generally less than the levels set by the federal government.129 “Refined” forms (which would include calcium citrate malate [CCM], calcium citrate, and most calcium carbonate) have low levels of lead.130 More recently, a survey of over-the-counter calcium supplements found low or undetectable levels of lead in most products,131 representing a sharp decline in lead content of calcium supplements since 1993. People who decide to take bone meal, dolomite, oyster shell, or coral calcium for long periods of time can contact the supplying supplement company to request independent laboratory analysis showing minimal lead levels.
References
1. Leela R, Yasodhara P, Ramaraju MBBS, Ramaraju LA. Calcium and magnesium in pregnancy. Nutr Res 1991;11:1231–6.
2. Prada JA, Ross R, Clark KE. Hypocalcemia and pregnancy-induced hypertension produced by maternal fasting. Hypertension 1992;20:620–6.
3. Marcous S, Brisson J, Fabia J. Calcium intake from dairy products and supplements and the risk of preeclampsia and gestational hypertension. Am J Epidemiol 1991;133:1226–72.
4. Ortega RM, Martinez RM, Lopez-Sobaler AM, et al. Influence of calcium intake on gestational hypertension. Ann Nutr Metab 1999;43:37–46.
5. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275:1113–7.
6. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275:1113–7.
7. Lopez-Jaramillo P, Narvaez M, Weigle RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648–55.
8. Cong K, Chi S, Lui G. Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chin Med J 1995;108:57–9.
9. Purwar M, Kulkarni, H, Motghare V, Dhole S. Calcium supplementation and prevention of pregnancy induced hypertension. J Obstet Gynaecol Res 1996;22:425–30.
10. Belizán JM, Villar J, Gonzalez L, et al. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399–405.
11. Sanchez-Ramos L, Briones DK, Kaunitz AM, et al. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol 1994;84:349–53.
12. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. N Engl J Med 1997;337:69–76.
13. NIH Consensus Development Panel on Optimal Calcium Intake. Optimal calcium intake. Nutrition 1995;11:409–17.
14. Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ 1997;157:907–19.
15. Cong K, Chi S, Lui G. Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chin Men J 1995;108:57–9.
16. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. JAMA 1996;275:1113–7.
17. Lopez-Jaramillo P, Narvaez M, Weigel RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648–55.
18. Purwar M, Julkarni H, Motghare V, Dhole S. Calcium supplementation and prevention of pregnancy induced hypertension. J Obstet Gynaecol Res 1996;22:425–30.
19. Sanchez-Ramos L, Briones DK, Kaunitz AM, et al. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. Obstet Gynecol 1994;84:349–53.
20. Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. CMAJ 1997;157:907–19.
21. Cong K, Chi S, Lui G. Calcium supplementation during pregnancy for reducing pregnancy induced hypertension. Chin Men J 1995;108:57–9.
22. Reid IR, Ames RW, Evans MC, et al. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med 1995;98:331–5.
23. Hosking DJ, Ross PD, Thompson DE, et al. Evidence that increased calcium intake does not prevent early postmenopausal bone loss. Clin Ther 1998;20:933–44.
24. Owusu W, Willett WC, Feskanich D, et al. Calcium intake and the incidence of forearm and hip fractures among men. J Nutr 1997;127:1782–7.
25. Rulm LA, Sakhaee K, Peterson R, et al. The effect of calcium citrate on bone density in the early and mid-postmenopausal period: a randomized, placebo-controlled study. Am J Ther 1999;6:303–11.
26. Nieves JW, Komar L, Cosman F, Lindsay R. Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr 1998;67:18–24.
27. Bonjour JP, Carrie AL, Ferrari S, et al. Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 1997;99:1287–94.
28. Welten DC, Kemper HC, Post GB, et al. A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J Nutr 1995;125:2802–13.
29. Heaney RP, Nordin BEC. Calcium effects on phosphorus absorption: implications for the prevention and co-therapy of osteoporosis.J Am Coll Nutr 2002;21:239–44.
30. Abraham GE, Grewal H. A total dietary program emphasizing magnesium instead of calcium. J Reprod Med 1990;35:503–7.
31. 33. Hojo M, August P. Calcium metabolism in normal and hypertensive pregnancy. *Semin Nephrol* 1995;15:504–11 [review].
32. Hojo M, August P. Calcium Metabolism in Preeclampsia: Supplementation may help. *Medscape Womens Health* 1997;2:5.
33. Moutquin JM, Garner PR, Burrows RF, et. al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. *CMAJ* 1997;157:907–19.
34. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. *N Engl J Med* 1997;337:69–76.
35. Belizan JM, Villar J, Gonzalez, et al. Calcium supplementation to prevent hypertensive disorders of pregnancy. *N Engl J Med* 1991;325:1399–405.
36. Hojo M, August P. Calcium Metabolism in Preeclampsia: Supplementation may help. *Medscape Womens Health* 1997;2:5.
37. Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. *CMAJ* 1997;157:907–19.
38. Crowther CA, Hiller JE, Pridmore B, et al. Calcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia, and preterm birth: an Australian randomized trial. FRACOG and the ACT study group. *Aust N Z J Obstet Gynaecol* 1999;39:12–8.
39. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. *JAMA* 1996;275:1113–7.
40. Belizan JM, Villar J, Gonzalez, et al. Calcium supplementation to prevent hypertensive disorders of pregnancy. *N Engl J Med* 1991;325:1399–405.
41. Herrera JA, Arevalo-Herrera M, Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. *Obstet Gynecol* 1998;91:585–90.
42. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. *N Engl J Med* 1997;337:69–76.
43. Villar J, Abdel-Aleem H, Merialdi M, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. *Am J Obstet Gynecol* 2006;194:639–49.
44. Villar J, Abdel-Aleem H, Merialdi M, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. *Am J Obstet Gynecol* 2006;194:639–49.
45. Bucher HC, Guyatt GH, Cook RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia: a meta-analysis of randomized controlled trials. *JAMA* 1996;275:1113–7.
46. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. *N Engl J Med* 1997;337:69–76.
47. Sibai BM. Prevention of preeclampsia: a big disappointment. *Am J Obstet Gynecol* 1998;179:1275–8.
48. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent preeclampsia. *N Engl J Med* 1997;337:69–76.
49. Lopez-Jaramillo P, Narvaez M, Weigel RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. *Br J Obstet Gynaecol* 1989;96:648–55.
50. Lopez-Jaramillo P, Narvaez M, Felix C, Lopez A. Dietary calcium supplementation and prevention of pregnancy hypertension. *Lancet* 1990;335:293. [letter]
51. Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. *Am J Obstet Gynecol* 1990;163:1124–31.
52. Belizan JM, Villar J, Gonzalez L. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399–405.
53. Belizan JM, Villar J, Gonzalez L. Calcium supplementation to prevent hypertensive disorders of pregnancy. *N Engl J Med* 1991;325:1399–405.
54. Sanchez-Ramos L, Briones DK, Kaunitz AM, et al. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients. *Obstet Gynecol* 1994;84:349–53.
55. DerSimonian R, Levine RJ. Resolving discrepancies between a meta-analysis and a subsequent large controlled trial. *JAMA* 1999;282:664–70 [review].
56. Ritchie LD, King JC. Dietary calcium and pregnancy-induced hypertension: is there a relation? *Am J Clin Nutr* 2000;71(5 Suppl):1371–4S [review].
57. Villar J, Belizan JM. Same nutrient, different hypotheses: disparities in trials of calcium supplementation during pregnancy. *Am J Clin Nutr* 2000;71(5 Suppl):1375–9S [review].
58. NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake. *JAMA* 1994;272(24):1942 [review].
59. Moutquin JM, Garner PR, Burrows RF, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy. *CMAJ* 1997;157:907–19.
60. Rossignol AM, Bonnlander H. Premenstrual symptoms and beverage consumption. Am J Obstet Gynecol 1993;168:1640 [letter].
61. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Am J Obstet Gynecol 1998;179:444–52.
62. Thys-Jacobs S, Ceccarelli S, Bierman A, et al. Calcium supplementation in premenstrual syndrome. J Gen Intern Med 1989;4:183–9.
63. Penland JG, Johnson PE. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 1993;168:1417–23.
64. Connon JJ. Celiac disease. In: Shils ME, Olson JA, Shike M, eds. Modern Nutrition in Health and Disease, 8th ed. Philadelphia: Lea & Febiger, 1994, 1062.
65. Crofton RW, Glover SC, Ewen SWB, et al. Zinc absorption in celiac disease and dermatitis herpetiformis: a test of small intestinal function. Am J Clin Nutr 1983;38:706–12.
66. Solomons NW, Rosenberg IH, Sandstead HH. Zinc nutrition in celiac sprue. Am J Clin Nutr 1976;29:371–5.
67. Rude RK, Olerich M. Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 1996;6:453–61.
68. Yacowitz H, Fleischman AI, Bierenbaum ML. Effects of oral calcium upon serum lipids in man. Br Med J 1965;1:1352–4.
69. Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992;152:2441–4.
70. Karanja N, Morris CD, Illingworth DR, Plasma lipids and hypertension: response to calcium supplementation. Am J Clin Nutr 1987;45:60–5.
71. Denke MA, Fox MM, Schulte MC. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 1993;123:1047–53.
72. Bostick RM, Fosdick L, Grandits GA, et al. Effect of calcium supplementation on serum cholesterol and blood pressure. Arch Fam Med 2000;9:31–9.
73. Bierenbaum ML, Fleischman AI, Raichelson RI. Long term human studies on the lipid effects of oral calcium. Lipids 1972;7:202–6.
74. Carlson LA, Olsson AG, Oro L, Rossner S. Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemia. Atherosclerosis 1971;14:391–400.
75. Griffith LE, Guyatt GH, Cook RJ, et al. The influence of dietary and nondietary calcium supplementation on blood pressure. An updated metaanalysis of randomized controlled trials. Am J Hypertens 1999;12:84–92.
76. Zemel MB, Thompson W, Milstead A, et al. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 2004;12:582–90.
77. Shapses SA, Heshka S, Heymsfield SB. Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab 2004;89:632–7.
78. Truswell AS. ABC of nutrition. Nutrition for pregnancy. Br Med J 1985;291:263–6.
79. Villar J, Repke JT. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 1990;163:1124–31.
80. Ritchie LD, King JC. Dietary calcium and pregnancy-induced hypertension: is there a relation? Am J Clin Nutr 2000;71(5 Suppl):1371S–4S [review].
81. Villar J, Belizan JM. Same nutrient, different hypotheses: disparities in trials of calcium supplementation during pregnancy. Am J Clin Nutr 2000;71(5 Suppl):1375S–9S [review].
82. Koo WWK, Walters JC, Esterlitz J, et al. Maternal calcium supplementation and fetal bone mineralization. Obstet Gynecol 1999;94:577–82.
83. Baer JT, Taper LJ, Gwazdauskas FG, et al. Diet, hormonal, and metabolic factors affecting bone mineral density in adolescent amenorrheic and eumenorrheic female runners. J Sports Med Phys Fitness 1992;32:51–8.
84. Kalkwarf HJ, Specker BL, Ho M. Effects of calcium supplementation on calcium homeostasis and bone turnover in lactating women. J Clin Endocrinol Metab 1999;84:464–70.
85. Fagan KM. Pharmacologic management of athletic amenorrhea. Clin Sports Med 1998;17:327–41 [review].
86. Whelan RL, Horvath KD, Gleason NR, et al. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum 1999;42:212–7.
87. White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 1997;6:769–74.
88. Kampman E, Slattery ML, Caan B, Potter JD. Calcium, vitamin D, sunshine exposure, dairy products and colon cancer risk (United States). Cancer Causes Control 2000;11:459–466.
89. Neugut AI, Horvath K, Whelan RL, et al. The effect of calcium and vitamin supplements on the incidence and recurrence of colorectal adenomatous polyps. Cancer 1996;78:723–8.
90. Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101–7.
91. Bostick RM, Fosdick L, Wood JR, et al. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial. J Natl Cancer Inst 1995;87:1307–15.
92. Cats A, Kleibeuker JH, van der Meer R, et al. Randomized, double-blinded, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 1995;87:598–603.
93. Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303–7.
94. Arasteh K. A beneficial effect of calcium intake on mood. J Orthomolec Med 1994;9:199–204.
95. Penland J, Johnson P. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol 1993;168:1417–23.
96. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Am J Obstet Gyencol 1998;179:444–52.
97. Krook L, Lutwak L, Whalen JP, et al. Human periodontal disease. Morphology and response calcium therapy. Cornell Vet 1972;62:32–53.
98. Uhrbom E, Jacobson L. Calcium and periodontitis: a clinical effect of calcium medication. J Clin Periodontol 1984;11:230–41.
99. Sanchez M, de la Sierra A, Coca A, Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension 1997;29:531–6.
100. Marshall RW, Cochran M, Hodgkinson A. Relationship between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone forming subjects. Clin Sci 1972;43:91–9.
101. Lemann J Jr. Composition of the diet and calcium kidney stones. N Engl J Med 1993;328:880–2 [editorial].
102. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833–8.
103. Hassapidou MN, Paraskevopoulos S Th, Karakoltsidis PA, et al. Dietary habits of patients with renal stone disease in Greece. J Human Nutr Dietet 1999;12:47–51.
104. Sowers MFR, Hannausch M, Wood C, et al. Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol 1998;147:914–20.
105. Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497–504.
106. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. A prospective study of dietary and supplemental calcium and the risk of kidney stones in women. Am J Epidemiol 1996;143(11Suppl):S15 [abstr #57].
107. Pak CY. Nephrolithiasis from calcium supplementation. J Urol 1987;137:1212–3 [editorial].
108. Levine BS, Rodman JS, Wienerman S, et al. Effect of calcium citrate supplementation on urinary calcium oxalate saturation in female stone formers: implications for prevention of osteoporosis. Am J Clin Nutr 1994;60:592–6.
109. Pak CY, Sakhaee K, Hwang TIS, et al. Nephrolithiasis from calcium supplementation. J Urol 1987;137:1212–3 [editorial/review].
110. Bataille IP, Charransol G, Gregoire I, et al. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophsiological groups with calcium stones. J Urol 1983;130:218–23.
111. Bataille P, Charransol G, Gregoire I, et al. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophsiological groups with calcium stones. J Urol 1983;130:218–23.
112. Thys-Jacobs S. Vitamin D and calcium in menstrual migraine. Headache 1994;34:544–6.
113. Thys-Jacobs S. Alleviation of migraines with therapeutic vitamin D and calcium. Headache 1994;34:590–2.
114. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypothesis 1986;21:193–200.
115. DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev 1998;56(2 Pt 2):S4–10 [review].
116. Yasui M, Yase Y, Ando K, et al. Magnesium concentration in brains from multiple sclerosis patients. Acta Neurol Scand 1990;81:197–200.
117. Yasui M, Ota K. Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis. Magnes Res 1992;5:295–302.
118. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington DC: National Academy Press, 1997, 108–17 [review].
119. Heaney RP, Recker RR, Weaver CM. Absorbability of calcium sources: the limited role of solubility. Calcif Tissue Int 1990;46:300–4.
120. Sheikh MS, Santa Ana CA, Nicar MJ, et al. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532–6.
121. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev 1994;52:221–32 [review].
122. Heaney RP, Nordin BEC. Calcium effects on phosphorus absorption: implications for the prevention and co-therapy of osteoporosis.J Am Coll Nutr 2002;21:239–44.
123. Kruger MC, Horrobin DF. Calcium metabolism, osteoporosis and essential fatty acids: a review. Prog Lipid Res 1997;36:131–51 [review].
124. Civitelli R, Villareal DT, Agnusdei D, et al. Dietary L-lysine and calcium metabolism in humans. Nutrition 1992;8:400–5.
125. Flodin NW. The metabolic roles; pharmacology, and toxicology of lysine. J Am Coll Nutr 1997;16:7–21 [review].
126. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev 1994;52:221–32 [review].
127. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691.
128. Lewis JR, Calver J, Zhu K, et al. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. J Bone Miner Res 2011;26:35–41.
129. Burros M. Testing calcium supplements for lead. New York Times June 4, 1997, B7.
130. Bourgoin BP, Evans DR, Cornett JR, et al. Lead content in 70 brands of dietary calcium supplements. Am J Public Health 1993;83:1155–60.
131. Ross EA, Szabo NJ, Tebbett IR. Lead content of calcium supplements. JAMA 2000;284:1425–9.
Last Review: 08-17-2011
Copyright © 2011 Aisle7. All rights reserved. www.Aisle7.net
Learn more about Aisle7, the company.
The information presented in Aisle7 is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires June 2013.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
